Novelion Therapeutics Inc. announced the appointment of Mark Corrigan, M.D. to its board of directors, effective immediately. Dr. Corrigan will serve as a member of the compliance committee. Dr. Corrigan was previously president and chief executive officer of Zalicus Inc. Dr. Corrigan currently serves on the board of directors of Cardiome Pharma Corp. and on the supervisory board of Nabriva Therapeutics AG. The company also announced that effective immediately, Sandford Smith will step down from the Novelion Board of Directors.